These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34961702)

  • 1. Relationship between gene mutations and clinicopathological features in nonampullary duodenal epithelial tumors.
    Fukusada S; Shimura T; Iwasaki H; Okuda Y; Katano T; Ozeki T; Kitagawa M; Nishie H; Tanaka M; Ozeki K; Kubota E; Tanida S; Kataoka H
    Dig Liver Dis; 2022 Jul; 54(7):905-910. PubMed ID: 34961702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of KRAS Mutation in Patients With Sporadic Nonampullary Duodenal Epithelial Tumors.
    Kinugasa H; Kanzaki H; Tanaka T; Yamamoto S; Yamasaki Y; Nouso K; Ichimura K; Nakagawa M; Mitsuhashi T; Okada H
    Clin Transl Gastroenterol; 2021 Nov; 12(11):e00424. PubMed ID: 34797780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
    Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
    J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal Neoplasms of Gastric Phenotype: An Immunohistochemical and Genetic Study With a Practical Approach to the Classification.
    Hida R; Yamamoto H; Hirahashi M; Kumagai R; Nishiyama K; Gi T; Esaki M; Kitazono T; Oda Y
    Am J Surg Pathol; 2017 Mar; 41(3):343-353. PubMed ID: 27984236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.
    Kojima Y; Ohtsuka K; Ohnishi H; Abe N; Furuse J; Watanabe T; Sugiyama M
    Surg Today; 2018 Aug; 48(8):765-772. PubMed ID: 29525853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of non-ampullary duodenal tumors and their phenotypic classification.
    Yoshida M; Shimoda T; Abe M; Kakushima N; Kawata N; Takizawa K; Ono H; Sugino T
    Pathol Int; 2019 Jul; 69(7):398-406. PubMed ID: 31328367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
    Matsubara A; Ogawa R; Suzuki H; Oda I; Taniguchi H; Kanai Y; Kushima R; Sekine S
    Br J Cancer; 2015 Apr; 112(8):1398-404. PubMed ID: 25867268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas.
    Ota R; Sawada T; Tsuyama S; Sasaki Y; Suzuki H; Kaizaki Y; Hasatani K; Yamamoto E; Nakanishi H; Inagaki S; Tsuji S; Yoshida N; Doyama H; Minato H; Nakamura K; Kasashima S; Kubota E; Kataoka H; Tokino T; Yao T; Minamoto T
    J Pathol; 2020 Nov; 252(3):330-342. PubMed ID: 32770675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Features and Magnifying Chromoendoscopic Findings of Non-Ampullary Duodenal Epithelial Tumors.
    Toya Y; Endo M; Akasaka R; Urushikubo J; Gonai T; Asakura K; Yanai S; Kawasaki K; Eizuka M; Uesugi N; Nakamura S; Sugai T; Matsumoto T
    Digestion; 2018; 97(3):219-227. PubMed ID: 29428955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma.
    Minatsuki C; Yamamichi N; Inada KI; Takahashi Y; Sakurai K; Shimamoto T; Tsuji Y; Shiogama K; Kodashima S; Sakaguchi Y; Niimi K; Ono S; Niwa T; Ohata K; Matsuhashi N; Ichinose M; Fujishiro M; Tsutsumi Y; Koike K
    Dig Dis Sci; 2018 Oct; 63(10):2617-2625. PubMed ID: 29956011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Immunophenotype and Clinicopathological Findings for Superficial Nonampullary Duodenal Epithelial Tumor.
    Fukusada S; Shimura T; Iwasaki H; Okuda Y; Katano T; Nishigaki R; Ozeki T; Kitagawa M; Nishie H; Tanaka M; Ozeki K; Kubota E; Tanida S; Kataoka H
    Digestion; 2021; 102(6):870-877. PubMed ID: 33794536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic and biopsy diagnoses of superficial, nonampullary, duodenal adenocarcinomas.
    Kakushima N; Kanemoto H; Sasaki K; Kawata N; Tanaka M; Takizawa K; Imai K; Hotta K; Matsubayashi H; Ono H
    World J Gastroenterol; 2015 May; 21(18):5560-7. PubMed ID: 25987780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Tatsuguchi A; Yamada T; Ueda K; Furuki H; Hoshimoto A; Nishimoto T; Omori J; Akimoto N; Gudis K; Tanaka S; Fujimori S; Shimizu A; Iwakiri K
    BMC Cancer; 2022 Jul; 22(1):723. PubMed ID: 35778698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.
    Fu T; Guzzetta AA; Jeschke J; Vatapalli R; Dave P; Hooker CM; Morgan R; Iacobuzio-Donahue CA; Liu B; Ahuja N
    Int J Cancer; 2013 Jun; 132(11):2502-9. PubMed ID: 23065691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic features of nonampullary duodenal tumors with narrow-band imaging.
    Yoshimura N; Goda K; Tajiri H; Ikegami M; Nakayoshi T; Kaise M
    Hepatogastroenterology; 2010; 57(99-100):462-7. PubMed ID: 20698209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
    Wagner PL; Chen YT; Yantiss RK
    Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
    J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.